Drug Type Biosimilar, Monoclonal antibody |
Synonyms Recombinant human monoclonal antibody specific for human tumor necrosis factor(North China Pharma), 重组人源抗人肿瘤坏死因子 (TNF-α)单克隆抗体 (华北制药) |
Target |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ankylosing Spondylitis | Phase 1 | CN | 06 Jul 2020 | |
Ankylosing Spondylitis | Phase 1 | CN | 06 Jul 2020 | |
Psoriasis | Phase 1 | CN | 06 Jul 2020 | |
Psoriasis | Phase 1 | CN | 06 Jul 2020 | |
Rheumatoid Arthritis | Phase 1 | CN | 06 Jul 2020 | |
Rheumatoid Arthritis | Phase 1 | CN | 06 Jul 2020 |